[HTML][HTML] Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis

LM Nilsson, TZ Plym Forshell, S Rimpi, C Kreutzer… - PLoS …, 2012 - journals.plos.org
LM Nilsson, TZ Plym Forshell, S Rimpi, C Kreutzer, W Pretsch, GW Bornkamm, JA Nilsson
PLoS genetics, 2012journals.plos.org
c-Myc (hereafter called Myc) belongs to a family of transcription factors that regulates cell
growth, cell proliferation, and differentiation. Myc initiates the transcription of a large cast of
genes involved in cell growth by stimulating metabolism and protein synthesis. Some of
these, like those involved in glycolysis, may be part of the Warburg effect, which is defined
as increased glucose uptake and lactate production in the presence of adequate oxygen
supply. In this study, we have taken a mouse-genetics approach to challenge the role of …
c-Myc (hereafter called Myc) belongs to a family of transcription factors that regulates cell growth, cell proliferation, and differentiation. Myc initiates the transcription of a large cast of genes involved in cell growth by stimulating metabolism and protein synthesis. Some of these, like those involved in glycolysis, may be part of the Warburg effect, which is defined as increased glucose uptake and lactate production in the presence of adequate oxygen supply. In this study, we have taken a mouse-genetics approach to challenge the role of select Myc-regulated metabolic enzymes in tumorigenesis in vivo. By breeding λ-Myc transgenic mice, ApcMin mice, and p53 knockout mice with mouse models carrying inactivating alleles of Lactate dehydrogenase A (Ldha), 3-Phosphoglycerate dehydrogenase (Phgdh) and Serine hydroxymethyltransferase 1 (Shmt1), we obtained offspring that were monitored for tumor development. Very surprisingly, we found that these genes are dispensable for tumorigenesis in these genetic settings. However, experiments in fibroblasts and colon carcinoma cells expressing oncogenic Ras show that these cells are sensitive to Ldha knockdown. Our genetic models reveal cell context dependency and a remarkable ability of tumor cells to adapt to alterations in critical metabolic pathways. Thus, to achieve clinical success, it will be of importance to correctly stratify patients and to find synthetic lethal combinations of inhibitors targeting metabolic enzymes.
PLOS